| The Cancer Genome Atlas Pan-Cancer analysis project JMS The Cancer Genome Atlas Research Network, John N Nature Genetics 45 (10), 1113–1120, 2013 | 4603* | 2013 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 1511 | 2018 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1297 | 2014 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 967* | 2020 |
| Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel A González-Pérez, N López-Bigas The American Journal of Human Genetics 88 (4), 440-449, 2011 | 814 | 2011 |
| Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes MDM Leiserson, F Vandin, HT Wu, JR Dobson, JV Eldridge, JL Thomas, ... Nature genetics 47 (2), 106-114, 2015 | 761 | 2015 |
| IntOGen-mutations identifies cancer drivers across tumor types A Gonzalez-Perez, C Perez-Llamas, J Deu-Pons, D Tamborero, ... Nature Methods, 2013 | 503 | 2013 |
| Comprehensive identification of mutational cancer driver genes across 12 tumor types LBN Tamborero D*, Gonzalez-Perez A*, Perez-Llamas C Scientific Reports 3, 2650, 2013 | 475* | 2013 |
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes D Tamborero, A Gonzalez-Perez, N Lopez-Bigas Bioinformatics 29 (18), 2238-2244, 2013 | 360 | 2013 |
| Functional impact bias reveals cancer drivers A Gonzalez-Perez, N Lopez-Bigas Nucleic Acids Research 40 (21), e169, 2012 | 352 | 2012 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 339* | 2020 |
| Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations D Tamborero, C Rubio-Perez, J Deu-Pons, MP Schroeder, A Vivancos, ... Genome medicine 10 (1), 1-8, 2018 | 319 | 2018 |
| Pathway and network analysis of cancer genomes P Creixell, J Reimand, S Haider, G Wu, T Shibata, M Vazquez, ... Nature methods 12 (7), 615, 2015 | 307 | 2015 |
| In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities C Rubio-Perez, D Tamborero, MP Schroeder, AA Antolín, J Deu-Pons, ... Cancer cell 27 (3), 382-396, 2015 | 298 | 2015 |
| A compendium of mutational cancer driver genes F Martínez-Jiménez, F Muiños, I Sentís, J Deu-Pons, I Reyes-Salazar, ... Nature Reviews Cancer 20 (10), 555-572, 2020 | 291 | 2020 |
| Nucleotide excision repair is impaired by binding of transcription factors to DNA S Radhakrishnan, L Mularoni, J Deu-Pons, A Gonzalez-Perez, ... Nature, 264–267, 2016 | 258* | 2016 |
| A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, ... Annals of Oncology 29 (9), 1895-1902, 2018 | 247 | 2018 |
| Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia PG Ferreira, P Jares, D Rico, G Gómez-López, A Martínez-Trillos, ... Genome research 24 (2), 212-226, 2014 | 220 | 2014 |
| OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations L Mularoni, R Sabarinathan, J Deu-Pons, A Gonzalez-Perez, ... Genome biology 17 (1), 1-13, 2016 | 190 | 2016 |
| Computational approaches to identify functional genetic variants in cancer genomes Nature methods 10 (8), 723-729, 2013 | 175 | 2013 |
Nuria Lopez-BigasICREA Research Professor at the Institute for Research in BiomedicineVerified email at irbbarcelona.org
